Attention-deficit/hyperactivity disorder (ADHD) is often discussed in terms of visible traits: fidgeting, distractibility, ...

Medically reviewed by Kira Graves, PhD Takeaway ADHD can cause both noticeable hyperactive and impulsive behaviors and less obvious symptoms such as daydreaming, forgetfulness, and difficulty paying ...

ADHD was linked to troubling health problems in a new study.

In February, NZ rolled out new rules promising easier access to ADHD treatment. Today, gaps in training, cost and access show ...

Attention-deficit/hyperactivity disorder (ADHD) is characterized by a continuum of symptoms, including inattentiveness, impulsiveness, and hyperactivity, which can negatively impact daily life. In ...

A large Danish study found that children diagnosed with ADHD or autism today more closely resemble their peers in the general population than those diagnosed 10 years ago. The shift suggests that ...

Ever wondered why it feels like half your social feed has recently received an ADHD or autism diagnosis? While some dismiss the uptick as a social media trend, groundbreaking research published in ...

The pathogenesis of ADHD is not well understood, but norepinephrine and dopamine appear to play roles in the disorder because they modulate the area of the brain involved in attention and behavior ...

Doctronic reports that ADD is an outdated term and ADHD is the current diagnosis with three subtypes, affecting healthcare ...

More than half of adults seeking treatment for eating disorders may be living with undiagnosed ...

Demand for attention deficit hyperactivity disorder (ADHD) assessments risks delaying treatment for children with serious mental illness, a leading doctor has warned.

Novo Nordisk will pay $300 million upfront, and up to $2.6 billion in total, for Hengrui's once-weekly GLP-1/GIP pill, which has not been tested in people. North Carolina Budget Sends Over $10.7 ...